Identifiers
secreted protein acidic and cysteine rich
HUGO:SPARC hgnc_id:HGNC:11219 HGNC:11219 ENTREZ:6678 UNIPROT:P09486
Maps_Modules
HMC:TUMOR_PROMOTING_INFLAMMATION
HMC:ACTIVATING_INVASION_AND_METASTASIS
Cancer Associated Fibroblasts / FIBROBLAST_ACTIVATION_MARKERS
Cancer Associated Fibroblasts / CAF_INHIBITION_ANTITUMOR
References
PMID:17260013
SPARC prevents fibroblast activation in 293 xenografts, suggesting that the anti-cancer effects of SPARC may be due, at least in part, to the formation of tumor stroma that is not supportive of tumor growth.
PMID:17235047
SPARC is a marker of fibroblast activation
patients whose pancreatic cancer stromal fibroblasts expressed SPARC (median survival, 15 months) had a significantly worse prognosis than patients whose tumor stroma did not express SPARC (median survival, 30 months; In contrast, the expression of SPARC in pancreatic cancer cells was not associated with prognosis